Updated on 15 July 2013
What are your short-term plans for SIIL? Would it follow the latest trend of FDI in pharma and look for foreign investors?
SIIL has already set footprints across the world in private market in various countries. Market expansion has been a part of ongoing strategic action plan of SIIL for a couple of years now.
What percentage of SIIL vaccines are used in domestic market?
We cater to all national requirements as per demand on priority basis. Besides, as our production capacities are very high and products are of international quality, we also export more than 80 percent of our vaccines.
What vaccines are under development currently at SIIL?
The vaccines that are currently under development at SIIL are Vero Rabies vaccine, Rota vaccine and Pneumococcal vaccine. They are under various stages of development in phase I/II/III.
Can you tell about talk about SII's plans for other biopharmaceutical products?
SIIL has already ventured into biopharmaceutical market with EPO, which is being marketed at most affordable price. Also, there are some other novel products in this segment, which are under various stages of development.